The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Inosine Pranobex Market Research Report 2024

Global Inosine Pranobex Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1411457

No of Pages : 88

Ask Your Query

Synopsis

Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.

The global Inosine Pranobex market was valued at US$ 201 million in 2023 and is anticipated to reach US$ 234.5 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.

Global Inosine Pranobex key players include Newport Pharmaceuticals, Gedeon Richter, etc. Global top two manufacturers hold a share about 50%.

Europe is the largest market, with a share about 55%, followed by North America and Japan, both have a share about 20 percent.

In terms of product, Tablet is the largest segment, with a share about 70%. And in terms of application, the largest application is Antiviral, followed by Immunomodulation, etc.

This report aims to provide a comprehensive presentation of the global market for Inosine Pranobex, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inosine Pranobex.

Report Scope

The Inosine Pranobex market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inosine Pranobex market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Inosine Pranobex manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Newport Pharmaceuticals
  • Gedeon Richter
  • Mochida
  • Sanofi
  • Andrómaco
  • Yung Shin
  • Alfasigma S.p.A.
  • Polfarmex
  • Sanfer
  • Meprofarm
  • Novell Pharmaceutical
  • Aflofarm

Segment by Type

  • Tablet
  • Syrup

Segment by Application

  • Immunomodulation
  • Antiviral
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inosine Pranobex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inosine Pranobex in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Inosine Pranobex Market Overview
1.1 Product Overview and Scope of Inosine Pranobex
1.2 Inosine Pranobex Segment by Type
1.2.1 Global Inosine Pranobex Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Syrup
1.3 Inosine Pranobex Segment by Application
1.3.1 Global Inosine Pranobex Market Value by Application: (2024-2030)
1.3.2 Immunomodulation
1.3.3 Antiviral
1.3.4 Other
1.4 Global Inosine Pranobex Market Size Estimates and Forecasts
1.4.1 Global Inosine Pranobex Revenue 2019-2030
1.4.2 Global Inosine Pranobex Sales 2019-2030
1.4.3 Global Inosine Pranobex Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Inosine Pranobex Market Competition by Manufacturers
2.1 Global Inosine Pranobex Sales Market Share by Manufacturers (2019-2024)
2.2 Global Inosine Pranobex Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Inosine Pranobex Average Price by Manufacturers (2019-2024)
2.4 Global Inosine Pranobex Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inosine Pranobex, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inosine Pranobex, Product Type & Application
2.7 Inosine Pranobex Market Competitive Situation and Trends
2.7.1 Inosine Pranobex Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inosine Pranobex Players Market Share by Revenue
2.7.3 Global Inosine Pranobex Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inosine Pranobex Retrospective Market Scenario by Region
3.1 Global Inosine Pranobex Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Inosine Pranobex Global Inosine Pranobex Sales by Region: 2019-2030
3.2.1 Global Inosine Pranobex Sales by Region: 2019-2024
3.2.2 Global Inosine Pranobex Sales by Region: 2025-2030
3.3 Global Inosine Pranobex Global Inosine Pranobex Revenue by Region: 2019-2030
3.3.1 Global Inosine Pranobex Revenue by Region: 2019-2024
3.3.2 Global Inosine Pranobex Revenue by Region: 2025-2030
3.4 North America Inosine Pranobex Market Facts & Figures by Country
3.4.1 North America Inosine Pranobex Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Inosine Pranobex Sales by Country (2019-2030)
3.4.3 North America Inosine Pranobex Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Inosine Pranobex Market Facts & Figures by Country
3.5.1 Europe Inosine Pranobex Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Inosine Pranobex Sales by Country (2019-2030)
3.5.3 Europe Inosine Pranobex Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inosine Pranobex Market Facts & Figures by Country
3.6.1 Asia Pacific Inosine Pranobex Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Inosine Pranobex Sales by Country (2019-2030)
3.6.3 Asia Pacific Inosine Pranobex Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Inosine Pranobex Market Facts & Figures by Country
3.7.1 Latin America Inosine Pranobex Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Inosine Pranobex Sales by Country (2019-2030)
3.7.3 Latin America Inosine Pranobex Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inosine Pranobex Market Facts & Figures by Country
3.8.1 Middle East and Africa Inosine Pranobex Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Inosine Pranobex Sales by Country (2019-2030)
3.8.3 Middle East and Africa Inosine Pranobex Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Inosine Pranobex Sales by Type (2019-2030)
4.1.1 Global Inosine Pranobex Sales by Type (2019-2024)
4.1.2 Global Inosine Pranobex Sales by Type (2025-2030)
4.1.3 Global Inosine Pranobex Sales Market Share by Type (2019-2030)
4.2 Global Inosine Pranobex Revenue by Type (2019-2030)
4.2.1 Global Inosine Pranobex Revenue by Type (2019-2024)
4.2.2 Global Inosine Pranobex Revenue by Type (2025-2030)
4.2.3 Global Inosine Pranobex Revenue Market Share by Type (2019-2030)
4.3 Global Inosine Pranobex Price by Type (2019-2030)
5 Segment by Application
5.1 Global Inosine Pranobex Sales by Application (2019-2030)
5.1.1 Global Inosine Pranobex Sales by Application (2019-2024)
5.1.2 Global Inosine Pranobex Sales by Application (2025-2030)
5.1.3 Global Inosine Pranobex Sales Market Share by Application (2019-2030)
5.2 Global Inosine Pranobex Revenue by Application (2019-2030)
5.2.1 Global Inosine Pranobex Revenue by Application (2019-2024)
5.2.2 Global Inosine Pranobex Revenue by Application (2025-2030)
5.2.3 Global Inosine Pranobex Revenue Market Share by Application (2019-2030)
5.3 Global Inosine Pranobex Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Newport Pharmaceuticals
6.1.1 Newport Pharmaceuticals Corporation Information
6.1.2 Newport Pharmaceuticals Description and Business Overview
6.1.3 Newport Pharmaceuticals Inosine Pranobex Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Newport Pharmaceuticals Inosine Pranobex Product Portfolio
6.1.5 Newport Pharmaceuticals Recent Developments/Updates
6.2 Gedeon Richter
6.2.1 Gedeon Richter Corporation Information
6.2.2 Gedeon Richter Description and Business Overview
6.2.3 Gedeon Richter Inosine Pranobex Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Gedeon Richter Inosine Pranobex Product Portfolio
6.2.5 Gedeon Richter Recent Developments/Updates
6.3 Mochida
6.3.1 Mochida Corporation Information
6.3.2 Mochida Description and Business Overview
6.3.3 Mochida Inosine Pranobex Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mochida Inosine Pranobex Product Portfolio
6.3.5 Mochida Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Inosine Pranobex Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Inosine Pranobex Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Andrómaco
6.5.1 Andrómaco Corporation Information
6.5.2 Andrómaco Description and Business Overview
6.5.3 Andrómaco Inosine Pranobex Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Andrómaco Inosine Pranobex Product Portfolio
6.5.5 Andrómaco Recent Developments/Updates
6.6 Yung Shin
6.6.1 Yung Shin Corporation Information
6.6.2 Yung Shin Description and Business Overview
6.6.3 Yung Shin Inosine Pranobex Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Yung Shin Inosine Pranobex Product Portfolio
6.6.5 Yung Shin Recent Developments/Updates
6.7 Alfasigma S.p.A.
6.6.1 Alfasigma S.p.A. Corporation Information
6.6.2 Alfasigma S.p.A. Description and Business Overview
6.6.3 Alfasigma S.p.A. Inosine Pranobex Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Alfasigma S.p.A. Inosine Pranobex Product Portfolio
6.7.5 Alfasigma S.p.A. Recent Developments/Updates
6.8 Polfarmex
6.8.1 Polfarmex Corporation Information
6.8.2 Polfarmex Description and Business Overview
6.8.3 Polfarmex Inosine Pranobex Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Polfarmex Inosine Pranobex Product Portfolio
6.8.5 Polfarmex Recent Developments/Updates
6.9 Sanfer
6.9.1 Sanfer Corporation Information
6.9.2 Sanfer Description and Business Overview
6.9.3 Sanfer Inosine Pranobex Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sanfer Inosine Pranobex Product Portfolio
6.9.5 Sanfer Recent Developments/Updates
6.10 Meprofarm
6.10.1 Meprofarm Corporation Information
6.10.2 Meprofarm Description and Business Overview
6.10.3 Meprofarm Inosine Pranobex Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Meprofarm Inosine Pranobex Product Portfolio
6.10.5 Meprofarm Recent Developments/Updates
6.11 Novell Pharmaceutical
6.11.1 Novell Pharmaceutical Corporation Information
6.11.2 Novell Pharmaceutical Inosine Pranobex Description and Business Overview
6.11.3 Novell Pharmaceutical Inosine Pranobex Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Novell Pharmaceutical Inosine Pranobex Product Portfolio
6.11.5 Novell Pharmaceutical Recent Developments/Updates
6.12 Aflofarm
6.12.1 Aflofarm Corporation Information
6.12.2 Aflofarm Inosine Pranobex Description and Business Overview
6.12.3 Aflofarm Inosine Pranobex Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Aflofarm Inosine Pranobex Product Portfolio
6.12.5 Aflofarm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inosine Pranobex Industry Chain Analysis
7.2 Inosine Pranobex Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inosine Pranobex Production Mode & Process
7.4 Inosine Pranobex Sales and Marketing
7.4.1 Inosine Pranobex Sales Channels
7.4.2 Inosine Pranobex Distributors
7.5 Inosine Pranobex Customers
8 Inosine Pranobex Market Dynamics
8.1 Inosine Pranobex Industry Trends
8.2 Inosine Pranobex Market Drivers
8.3 Inosine Pranobex Market Challenges
8.4 Inosine Pranobex Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock